Evidence map›Paper›PMID 34274374›Full record

ArticleBehavioural brain research2021

Loss of SUR1 subtype K

Gerald Sakamaki, Kayla Johnson, Megan Mensinger, Eindray Hmu, Amanda H Klein

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Behavioural brain research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gerald SakamakiDepartment of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota, Duluth, MN, United States.
Kayla JohnsonDepartment of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota, Duluth, MN, United States.
Megan MensingerDepartment of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota, Duluth, MN, United States.
Eindray HmuDepartment of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota, Duluth, MN, United States.
Amanda H KleinDepartment of Pharmacy Practice and Pharmaceutical Sciences, University of Minnesota, Duluth, MN, United States. Electronic address: ahklein@d.umn.edu.
University of Minnesota, Duluth · US

Funding

KATP Channels as Downstream targets of adenylyl cyclases during opioid tolerance and withdrawalR01DA051876 · NIDA · UNIVERSITY OF MINNESOTA · PI KLEIN, AMANDA HELEN · 2021 to 2025
$2.9M
Altering potassium channel activity to investigate morphine tolerance and opiate induced hypersensitivityK01DA042902 · NIDA · UNIVERSITY OF MINNESOTA · PI KLEIN, AMANDA HELEN · 2018 to 2022
$726k
NIDA NIH HHS K01 DA042902NIDA NIH HHS R01 DA051876
6 · The paper itself

Abstract

Opioid signaling can occur through several downstream mediators and influence analgesia as well as reward mechanisms in the nervous system. K

Indexed as

Behavior, AnimalLocomotionNociceptionAnalgesics, OpioidAnimalsFemaleMaleMiceMice, Inbred C57BLMice, KnockoutSulfonylurea ReceptorsAbcc8 protein, mouseAnalgesics, OpioidSulfonylurea ReceptorsAnalgesiaK(ATP) channelLocomotionOpioidSUR1

Identifiers

PMID34274374
PMCPMC11019344
OpenAlexW3183342564

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.